Evidence map›Paper›PMID 22073013›Full record

ReviewMarine drugs2011

Kinase inhibitors from marine sponges.

Danielle Skropeta, Natalie Pastro, Ana Zivanovic

Open access · goldAbstract readReview
In one paragraph

Review in Marine drugs, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
7.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 68 citations in OpenAlex.

  1. Pyrrolo[2,1-RSC advances · 2024
    Review
  2. Bioinformatics and biology insights · 2024
    Article
  3. Review
  4. Organic extract ofOncology letters · 2022
    Article
  5. Review
  6. Review
  7. Review
  8. Putative role of natural products as Protein Kinase C modulator in different disease conditions.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2021
    Review
  9. Article
  10. Multipurpose Drugs Active Against BothFrontiers in cellular and infection microbiology · 2021
    Review
  11. Review
  12. Review
  13. The preparation of (4H)-imidazol-4-ones and their application in the total synthesis of natural products.Organic chemistry frontiers : an international journal of organic chemistry · 2020
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Marine anticancer drugs and their relevant targets: a treasure from the ocean.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Danielle SkropetaSchool of Chemistry, University of Wollongong, Wollongong, NSW 2522, Australia.
Natalie PastroSchool of Chemistry, University of Wollongong, Wollongong, NSW 2522, Australia.
Ana ZivanovicSchool of Chemistry, University of Wollongong, Wollongong, NSW 2522, Australia.
University of Wollongong · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protein kinases play a critical role in cell regulation and their deregulation is a contributing factor in an increasing list of diseases including cancer. Marine sponges have yielded over 70 novel compounds to date that exhibit significant inhibitory activity towards a range of protein kinases. These compounds, which belong to diverse structural classes, are reviewed herein, and ordered based upon the kinase that they inhibit. Relevant synthetic studies on the marine natural product kinase inhibitors have also been included.

Indexed as

AnimalsBiological ProductsCyclin-Dependent KinasesErbB ReceptorsGlycogen Synthase Kinase 3Mitogen-Activated Protein KinasesPoriferaProtein Kinase CProtein Kinase InhibitorsProtein-Tyrosine KinasesBiological ProductsCyclin-Dependent KinasesErbB ReceptorsGlycogen Synthase Kinase 3Mitogen-Activated Protein KinasesProtein Kinase CProtein Kinase InhibitorsProtein-Tyrosine Kinasesanticancer agentscell regulationmarine natural productsmarine spongesprotein kinase inhibitors

Identifiers

PMID22073013
PMCPMC3210622
OpenAlexW2035216120

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.